Cedric Bellanger

About Cedric Bellanger

Cédric Bellanger has served as a board member of Theraclion since 2022. Theraclion is a French listed medtech company focused on non-invasive ultrasound-based therapies, particularly through its SONOVEIN robotic platform for varicose vein treatment. Within the board, Bellanger brings a finance- and investment-oriented governance profile, which is especially relevant for a growth company operating in a capital-intensive, regulated and internationally expanding sector. His career combines financial expertise with entrepreneurial experience. He began in corporate finance at Signal Equity in New York, then moved to Schroders in London, where he specialized in trading. He later broadened his experience through entrepreneurship at Afriwara, an industrial and financial group active in more than 60 countries. Since 2020, he has been managing two family offices, giving him deep exposure to capital allocation, investment structuring and long-term value creation. Theraclion describes him as bringing a dual skill set: financial expertise and an entrepreneurial mindset. That combination is particularly valuable for a company such as Theraclion, which has to balance product development, regulatory execution, industrial scale-up and commercial expansion. His board role supports the company’s financial oversight and strategic decision-making, with a focus on funding discipline, shareholder value and the scaling of breakthrough medical technologies. Bellanger’s appointment also reflects Theraclion’s broader governance model, which brings together directors with complementary backgrounds in healthcare, private equity, consulting and investment. As a board member, he participates in supervising the company’s strategic direction and long-term priorities. This includes supporting a business whose technology aims to reduce the invasiveness of surgery and extend ultrasound-based treatment into additional indications beyond its core varicose vein application. In that context, Bellanger’s experience in finance, entrepreneurship and family office management helps strengthen the board’s ability to assess growth opportunities and capital strategy.